To examine the role of tumor necrosis factor-␣ (TNF␣) in mediating leptin secretion during an immunological challenge, we studied the effects of lipopolysaccharide (LPS) and TNF␣ on leptin secretion in endotoxin-sensitive C3H/HeOuJ (OuJ) mice, endotoxin-insensitive C3H/HeJ (HeJ) mice, and primary adipocytes cultured from both. Intraperitoneal injection of LPS increased plasma concentrations of TNF␣ and leptin in OuJ mice, but not in HeJ mice, suggesting a causal relationship between the induction of TNF␣ and leptin. Consistent with this idea, ip injection of recombinant murine TNF␣ increased plasma leptin in both OuJ and HeJ mice. To determine whether TNF␣ induces leptin secretion by acting directly on fat cells, primary adipocytes from OuJ and HeJ mice were cultured in the presence of TNF␣ or LPS. Whereas LPS was without effect on leptin secretion by adipocytes, TNF␣ induced a marked increase in the cell supernatant leptin concentration. These data demonstrate that TNF␣ plays a role in regulating the increase in leptin caused by LPS. Moreover, they show that TNF␣ can act directly on adipocytes to stimulate leptin secretion. Our results are consistent with the emerging view that leptin is a key hormone coupling immune system activity to energy balance. (Endocrinology 139: 2278 -2283, 1998) L EPTIN, the product of the ob gene (1), is a 16-kDa protein that has been identified as a blood-borne factor involved in long term regulation of food intake and energy expenditure (2-4). Leptin may be the missing element in the lipostat model (5), as it is secreted by fat cells, but acts on receptors that have been neuroanatomically mapped to several hypothalamic nuclei that are involved in satiety and energy expenditure (6 -10). Plasma leptin is positively related to adiposity (11), and both peripheral and central injection of leptin reduce food intake, increase energy expenditure, and deplete adipose tissue in lean mice (3). Thus, leptin links feeding behavior and metabolism to nutritional state, and when the leptin system is disrupted (i.e. leptin secretion and/or its receptors), as is the case in several models of obesity, there is a shift toward positive energy balance.
L EPTIN, the product of the ob gene (1) , is a 16-kDa protein that has been identified as a blood-borne factor involved in long term regulation of food intake and energy expenditure (2) (3) (4) . Leptin may be the missing element in the lipostat model (5) , as it is secreted by fat cells, but acts on receptors that have been neuroanatomically mapped to several hypothalamic nuclei that are involved in satiety and energy expenditure (6 -10) . Plasma leptin is positively related to adiposity (11) , and both peripheral and central injection of leptin reduce food intake, increase energy expenditure, and deplete adipose tissue in lean mice (3). Thus, leptin links feeding behavior and metabolism to nutritional state, and when the leptin system is disrupted (i.e. leptin secretion and/or its receptors), as is the case in several models of obesity, there is a shift toward positive energy balance.
In a number of autoimmune, infectious, and neoplastic diseases, there is a decrease in motivation for food and a number of metabolic irregularities that precipitate degradation of body protein and fat. This shift toward negative energy balance is generally attributed to proinflammatory cytokines, particularly tumor necrosis factor-␣ (TNF␣). The plasma TNF␣ concentration, however, is poorly correlated with anorexia and cachexia. If TNF␣ is involved in anorexia and cachexia, as evidence suggests, it probably acts in a paracrine fashion and, thus, interacts with the central nervous system indirectly, via a mechanism that is yet unknown. TNF␣ has long been known to alter the metabolism of fat cells (12) , and recent studies indicate a strong positive association between the activity of the TNF␣ system and plasma leptin (13) (14) (15) . Therefore, it is possible that at least part of the shift toward negative energy balance in sick animals is mediated by the induction of leptin by TNF␣.
Grunfeld et al. (16) and Sarraf et al. (17) were the first to report increased leptin gene expression in rodents after ip injection of lipopolysaccharide (LPS) or recombinant cytokines (e.g. TNF␣ and interleukin-1). It has recently been reported that TNF␣ increases leptin secretion in humans as well (18) . These results clearly indicated that immunological challenge can increase plasma leptin and, therefore, suggested that leptin may be an important hormone regulating food intake and metabolism in sick animals. However, these important findings do not preclude the possibility that LPS induces leptin production independent of cytokines, nor do they establish that cytokines act directly on adipocytes to induce leptin gene expression. This is particularly important because LPS and TNF␣ induce a variety of physiological responses, such as secretion of insulin (19) and adrenal corticosteroids (20, 21) , that have been shown to stimulate leptin production.
To address these issues, we measured plasma leptin in food-deprived C3H/HeOuJ (OuJ) and C3H/HeJ (HeJ) mice after the injection of LPS or recombinant murine TNF␣. These mouse strains are genetically similar except for a mutation in a single gene that has rendered macrophages from HeJ mice relatively insensitive to LPS (22) (23) (24) (25) . HeJ mice, therefore, are relatively resistant to LPS responses that are dependent upon proinflammatory cytokines (26 -28) . We also cultured primary adipocytes from OuJ and HeJ mice to determine whether LPS and TNF␣ induce leptin directly. The results of the present study indicate that LPS induces leptin via a cytokine-dependent mechanism, and that TNF␣ can act directly on adipocytes to stimulate leptin secretion.
Materials and Methods

Experimental animals
Ten-to 16-week old male (26 -32 g) OuJ and HeJ mice were obtained from a breeding colony maintained at the University of Illinois. Mice were housed in groups of three in polypropylene cages under a reverse 12-h light, 12-h dark cycle (lights on at 2100 h) with ad libitum access to water and rodent chow unless otherwise noted. All housing conditions and procedures were approved by the University of Illinois laboratory animal care advisory committee.
Treatment solutions and reagents
LPS from Escherichia coli serotype 0128:B8 (phenol extracted) was purchased from Sigma Chemical Co. (St. Louis, MO) and dissolved in Krebs-Ringer phosphate (KRP) for in vitro experiments or in sterile PBS (0.9% NaCl; Sigma Chemical) for ip injection. Recombinant murine TNF␣ purchased from Endogen (Woburn, MA) had a biological activity of 1.0 ϫ 10 8 U/mg and was specified by Endogen to contain less than 0.1 ng/g endotoxin. Murine TNF␣ was dissolved in sterile PBS with 1% BSA (detoxified tissue culture grade; Stem Cell Technologies, Vancouver, Canada) for ip injection or in KRP for in vitro studies. Bovine insulin (cell culture grade; Sigma Chemical Co.) was dissolved in sterile KRP.
Measurements
Leptin. The plasma or cell supernatant leptin concentration was measured using a commercially available, RIA specific for murine leptin (Linco Research, St. Charles, MO). The assay was conducted as specified by the manufacturer, except that all reagents were used at half the recommended volume. To validate this modification, pooled plasma samples from fasted mice and mice given ad libitum access to food [i.e. mice that had low (3.0 ng/ml) and high (6.9 ng/ml) plasma levels of leptin, respectively) were assayed using the recommended volumes and half the recommended volumes. Parallelism between the recommended and amended protocols was demonstrated. Cross-reactivity with insulin and glucagon was reported by Linco to be undetectable. The sensitivity of the assay was less than 0.2 ng/ml. The intraassay variation was 6.2%, and the interassay variation was less than 6.0%.
Plasma TNF␣. The plasma TNF␣ concentration was measured using a commercially available, solid phase, enzyme-linked immunosorbent assay (Genzyme Corp., Cambridge, MA) employing the multiple antibody sandwich principle. All samples were measured in one assay, and the intraassay variation was less than 4.7%.
Glycerol. The glycerol content of adipocyte supernatants was determined using the GPO-Trinder method (Sigma Chemical Co.). In brief, glycerol was phosphorylated to form glycerol-1-phosphate, which was oxidized to create dihydroxyacetone phosphate and peroxide. In the presence of 4-aminoantipyrine and sodium N-ethyl-N-(3-sulfopropyl)-m-anisidine, peroxide was cleaved by peroxidase to produce quinoneimine dye and water. The glycerol concentration was determined by comparing the spectrophotometric absorbance (540 nm; Gilford, Medfield, MA) of the sample to that of a glycerol standard.
Experimental protocol
Effect of LPS on plasma leptin in C3H/HeOuJ and C3H/HeJ mice.
Food was removed at 2100 h, and 12 h later, at the onset of darkness (i.e. 0900 h), OuJ mice were injected ip with 0.3 ml PBS containing 0 or 100 g LPS. Before and 2, 4, and 8 h after injection, mice were killed by CO 2 gas asphyxiation, and blood was collected into heparinized syringes by venipuncture of the inferior vena cava. Plasma obtained after centrifugation was stored at Ϫ80 C until it was assayed for leptin. A total of 40 mice were used in 2 separate, but identical, trials (n ϭ 5). In the second experiment, HeJ and OuJ mice were injected ip with 0.3 ml PBS containing 0 or 100 g LPS. Four hours postinjection, mice were killed by CO 2 gas asphyxiation, and plasma was collected and stored as described above until it was assayed for leptin and TNF␣. A total of 36 mice were used in 3 separate, but identical, trials (n ϭ 9).
Effect of recombinant murine TNF␣ on plasma leptin in C3H/HeOuJ and C3H/HeJ mice. After a 12-h fast, HeJ and OuJ mice were injected ip with 0.3 ml vehicle (PBS with 1% BSA) or vehicle containing 500 ng recombinant murine TNF␣. Four hours postinjection, mice were killed by CO 2 gas asphyxiation, and plasma was collected and stored as described above until it was assayed for leptin. A total of 24 mice were used in 2 separate, but identical, trials (n ϭ 6).
Effect of LPS and recombinant murine TNF␣ on leptin secretion by primary adipocytes.
Adipocytes were isolated as previously described (29) with slight modification. Mice were fasted for 2 h and then killed by cervical dislocation at the onset of the dark phase, when circulating leptin levels were anticipated to be at their nadir (17) . Epididymal fat pads were excised and minced into small pieces, and adipocytes were dissociated by a 35-min collagenase (1 mg/ml; Sigma) digestion in a 37 C shaking water bath. The resulting cell suspension was filtered through a 140-m mesh screen to remove any remaining tissue. Cells were then washed 4 times by centrifugation (500 ϫ g) in KRP containing 2 mg/ml dextrose (Sigma Chemical Co.) and 33 mg/ml BSA (fraction V; cell culture grade; Sigma) to remove contaminating cells. Adipocytes were counted, adjusted to 2 ϫ 10 6 cells/ml, and then plated in 0.5 ml KRP in 24-well plates. Adipocytes from OuJ mice were cultured with KRP, insulin (300 ng/ml), or LPS (10, 100, or 1000 ng/ml; n ϭ 6) for a period of 24 h. In a separate experiment, adipocytes from both OuJ and HeJ mice were cultured with KRP, insulin (300 ng/ml), or TNF␣ (1, 10, or 100 ng/ml; n ϭ 10) for 24 h. In both studies, medium was removed from beneath the floating monolayer and assayed for leptin and glycerol concentrations. To determine whether TNF␣ induced cell atrophy, adipocytes from OuJ mice cultured with KRP or TNF␣ (100 ng/ml) for 24 h were size fractionated by forward light scatter using an EPICS XL MCL flow cytometer (Coulter Electronics, Hialeah, FL) and EPICS Elite Workstation Software. A minimum of 10,000 events were analyzed for each treatment.
Statistical analysis
All data were analyzed using general linear model procedures. Data were subjected to one-way (treatment) or two-way (LPS ϫ time; treatment ϫ genotype) ANOVA to determine the significance of main factors and main factor interactions. When ANOVA revealed a significant effect of a main factor or an interaction between main factors, differences between treatment means were tested using paired t tests. All data are presented as the mean Ϯ se.
Results
LPS induces TNF␣ and leptin in C3H/HeOuJ mice, but not in C3H/HeJ mice
The first study was conducted to determine the effects of LPS over time on plasma leptin in LPS-sensitive OuJ mice. Mice were fasted for 12 h to reduce basal plasma leptin levels (17) and were injected ip with PBS or LPS (100 g/mouse). This dose of LPS was chosen because it induces behaviors indicative of sickness in OuJ, but not in HeJ, mice (28) . Leptin concentrations were determined from samples collected before injection and 2, 4, and 8 h postinjection. Two-way ANOVA of plasma leptin concentrations revealed a significant effect of LPS (P Ͻ 0.01), time (P Ͻ 0.01), and a LPS ϫ time interaction (P Ͻ 0.09). LPS increased plasma leptin at 4 h (P Ͻ 0.06) and 8 h (P Ͻ 0.03) postinjection (Fig. 1) . These data are consistent with a previous report that also showed LPS to increase plasma leptin in mice (17) .
HeJ mice are similar to OuJ mice, but because of a genetic mutation their macrophages are relatively insensitive to LPS (22, 23) . Therefore, in a second study HeJ mice were employed along with OuJ mice to determine whether secretion of leptin after LPS challenge is associated with secretion of TNF␣. OuJ and HeJ mice were subjected to a 12-h fast and injected with PBS or 100 g LPS. Because in the first experiment plasma leptin was maximally increased 4 h after injection of LPS, plasma was collected at this time point and assayed for leptin and TNF␣. As anticipated, two-way ANOVA of plasma TNF␣ and leptin levels revealed a significant effect of LPS (P Ͻ 0.01), genotype (P Ͻ 0.02), and a LPS ϫ genotype interaction (P Ͻ 0.01). Whereas LPS increased the plasma TNF␣ concentration in OuJ mice, it did not in HeJ mice (Fig. 2) . Consistent with the first study, OuJ mice receiving LPS had significantly higher plasma leptin levels than saline controls (Fig. 3) . However, plasma leptin levels in HeJ mice injected with LPS were not different from those in saline controls (Fig. 3) . Thus, LPS increased neither TNF␣ nor leptin in the plasma of HeJ mice.
Recombinant murine TNF␣ induces leptin in both C3H/ HeJ and C3H/HeOuJ mice
The results from the previous study suggested a causal relationship between the secretion of TNF␣ and leptin. To test this possibility, OuJ and HeJ mice were injected ip with saline or 500 ng TNF␣, and plasma collected 4 h postinjection was assayed for leptin. Two-way ANOVA of plasma leptin levels revealed a significant effect of TNF␣ (P Ͻ 0.01), but not genotype (P Ͻ 0.40). Both OuJ and HeJ mice injected with TNF␣ had significantly higher plasma leptin levels than saline controls (Fig. 4) . Therefore, HeJ mice were refractory to LPS, but not TNF␣.
TNF␣ induces lipolysis and leptin secretion by primary adipocytes
To determine whether TNF␣ interacts directly with adipocytes to induce leptin secretion, primary adipocytes from OuJ and HeJ mice were cultured in the presence of LPS or TNF␣. In an initial study, adipocytes cultured from OuJ mice were incubated in the presence of insulin (300 ng/ml) or LPS (0, 10, 100, or 1000 ng/ml) for 24 h. Supernatants were removed and assayed for leptin concentration. On the one hand, insulin, which was employed as a positive control (19) , induced a marked increase in the supernatant leptin con- centration. On the other hand, LPS did not affect leptin secretion in cultured adipocytes (Fig. 5) . Similarly, one-way ANOVA of glycerol revealed that LPS did not induce lipolysis, as measured by the supernatant glycerol content (data not shown). In a subsequent study, OuJ and HeJ adipocytes were cultured in the presence of insulin (300 ng/ml) or TNF␣ (0, 1, 10, or 100 ng/ml) for 24 h. One-way ANOVA of the leptin concentrations of supernatants from OuJ and HeJ adipocytes revealed significant effects of TNF␣ (P Ͻ 0.01). With regard to increased leptin secretion, adipocytes from HeJ mice responded to TNF␣ in a dose-dependent fashion (Fig.  6) . Adipocytes from OuJ mice responded similarly, but maximal leptin secretion was achieved at a lower concentration of TNF␣ (10 ng/ml; Fig. 6 ). Both OuJ and HeJ adipocytes secreted leptin in response to insulin. As TNF␣ is well known for its lipolytic effects, we also determined the cell supernatant concentration of glycerol. One-way ANOVA of the glycerol concentrations of supernatants from OuJ and HeJ adipocytes revealed significant effects of TNF␣ (P Ͻ 0.01). Consistent with previous studies, TNF␣ increased glycerol content in supernatants from both OuJ and HeJ adipocytes (Table 1) . Despite being lipolytic, however, flow cytometric analysis indicated that TNF␣ did not significantly alter the size distribution of adipocytes (data not shown).
Discussion
Induction of leptin after acute challenge with LPS may be involved in anorexia and weight loss, which are common in individuals with an acute or chronic Gram-negative bacterial infection. To determine whether the induction of TNF␣ by LPS is involved in the increased plasma leptin levels after challenge with LPS, we measured plasma leptin in OuJ and HeJ mice injected ip with LPS or recombinant murine TNF␣. The results of the present study confirm that LPS increases plasma levels of TNF␣ and leptin in LPS-sensitive OuJ mice. However, the important finding is that in LPS-insensitive HeJ mice, LPS induced neither TNF␣ nor leptin, suggesting a causal relationship between the induction of TNF␣ and leptin. This relationship was confirmed in a subsequent study in which administration of TNF␣ induced a similar increase in leptin in both OuJ and HeJ mice. Moreover, in vitro studies with primary adipocytes cultured from OuJ and HeJ mice showed that TNF␣, but not LPS, increased supernatant leptin levels. These data suggest that the secretion of TNF␣ is important for the increase in plasma leptin caused by LPS and show that TNF␣ can act directly on adipocytes to stimulate leptin secretion.
In the present study the secretion of leptin was compared in OuJ and HeJ mice injected with LPS or TNF␣. HeJ mice are genetically similar to OuJ mice, but, due to a defect in a single gene (Lps) on chromosome 4, are notably insensitive to LPS (26 -28) . Because previous studies concerning the mechanisms underlying the resistance of HeJ mice to LPS indicate that their macrophages secrete relatively low amounts of cytokines upon stimulation (22, 23) , they were an ideal model for determining the importance of cytokines in the induction of leptin by LPS. It is important to note that in HeJ mice, LPS can induce splenocyte proliferation (30, 31) , initiate complement activation (32) , induce shedding of p55 and p75 soluble TNF receptors (33) , and activate neutrophils (34) . Thus, LPS resistance in HeJ mice is not comprehensive. The results from the present study are consistent with recent studies that found LPS to increase leptin gene expression in LPS-responsive mice (16, 17) . In those studies it was also predicted, but not proven, that the induction of leptin by LPS was mediated by inflammatory cytokines. Although cytokines were not measured in plasma after LPS challenge, this idea was supported, as the injection of recombinant TNF␣, IL-1␤, and leukemia inhibitory factor increased plasma leptin levels (17) . The present results provide strong support for this hypothesis, particularly because 1) LPS increased plasma leptin and TNF␣ levels in OuJ mice; 2) in HeJ mice, in which LPS did not increase plasma TNF␣, it did not increase plasma leptin; and 3) injection of recombinant murine TNF␣ increased plasma leptin in both HeJ and OuJ mice.
Although these results suggested that the induction of leptin by LPS involved the secretion TNF␣, they did not establish a direct relationship between the cytokine and the adipocyte. Whether TNF␣ acted on fat cells to induce leptin secretion is an important question, as the hypothalamic-pituitary-adrenal axis is an early target for TNF␣ (35) , and glucocorticoids have been shown to stimulate leptin secretion (20, 21) . To answer this very specific question, the effects of LPS or TNF␣ on in vitro secretion of leptin by adipocytes cultured from OuJ and HeJ mice were assessed. Consistent with the idea that induction of leptin by LPS is dependent upon cytokines, adipocytes from neither OuJ nor HeJ mice secreted more leptin in response to LPS. However, adipocytes from both mouse strains responded to TNF␣ with increased secretion of leptin. Therefore, these results clearly indicate that TNF␣ can induce leptin secretion by direct interaction with the adipocyte.
Because leptin regulates food intake and energy expenditure in healthy animals, it is reasonable to postulate that it does so in sick animals as well. Supporting this idea, db/db mice, which lack a functional leptin receptor (36, 37) and are obese, are somewhat resistant to the anorectic properties of LPS (38) . In contrast, ob/ob mice that are obese because they carry a mutation that prevents leptin secretion are as responsive as normal littermates to the anorectic effects of LPS. Thus, the role of leptin in the anorexia induced by LPS or TNF␣ is not at all clear. Because cytokines and their receptors are present in the brain, it would be more surprising if leptin alone explained the anorexia. Indeed, ciliary neurotropic factor, a cytokine that activates a similar pattern of STAT (signal transducer and activator of transcription) factors as leptin, was found to reduce adiposity, hyperphagia, and hyperinsulinemia in ob/ob mice, db/db mice, and mice with dietinduced obesity, which are insensitive to leptin (39) . The finding that db/db mice, but not the ob/ob mice, are resistant to LPS-induced anorexia led Faggioni and colleagues (38) to hypothesize that other cytokines that share significant structural and sequential homology with leptin (40, 41) may signal through the functional leptin receptor in the ob/ob mouse. Leptin receptor density has been found to be increased in ob/ob mice compared with that in nonobese controls (42) . Although leptin was first described for its role in regulating energy balance, the primary purpose for the induction of leptin by TNF␣ need not be to regulate food intake and energy expenditure. Perhaps the purpose of the induction of leptin by TNF␣ is to direct or modulate immune function. For example, irradiated ob/ob mice replenished leukocytes more slowly than lean controls (43) , which implies that leptin plays a role in hematopoeisis. Several other studies provide evidence for this hypothesis, as primitive hematopoietic stem cells express some forms of the leptin receptor (44) , and addition of recombinant leptin to cultures of erythrocytic and myelopoietic cells induces their differentiation and proliferation (45). Gainsford and co-workers (46) found that addition of leptin to culture medium enhanced cytokine production and phagocytosis of Leishmania parasites by murine peritoneal macrophages. Furthermore, the phagocytic activity of liver macrophages is decreased in obese Zucker rats (fa/fa), which lack functional leptin receptors (47) . Collectively, these data suggest that leptin might also function within the FIG. 6. Recombinant murine TNF␣ induced leptin secretion by primary adipocytes cultured from either endotoxin-sensitive C3H/ HeOuJ mice or endotoxin-insensitive C3H/HeJ mice. Adipocytes were cultured for 24 h in the presence of insulin (300 ng/ml) or TNF␣ (0, 1, 10, or 100 ng/ml; n ϭ 10). Values are the mean Ϯ SE. *, Leptin concentrations significantly elevated compared with those in medium controls (P Ͻ 0.05). immune system to stimulate hematopoeisis and aid in the clearance of infectious organisms.
In summary, our results suggest that TNF␣ plays a role in regulating the increase in leptin caused by immunological challenge with LPS. Moreover, the present results show that TNF␣ can act directly on adipocytes to stimulate leptin secretion. Our results, therefore, are entirely consistent with the emerging view that leptin is a key hormone coupling immune system activity to energy balance. Understanding the mechanism by which inflammatory stimuli regulate leptin may provide new insights into the prevention of the anorexia and cachexia of disease.
